Somatic mutation analysis of exons 5–8 of the TP53 gene, which encode the DNA-binding region where cancer-associated mutations most frequently occur (23–25), indicates that genetic alterations of this gene may be implicated in the development of a limited fraction of PCs. The gene discussed is TP53; the disease is cancer.